Human Health and Potential (HHP)

Four newly discovered SARS-CoV-2 peptides not only promise to make COVID-19 tests cheaper and more specific, but may also reveal disease severity.

In a classic case of double trouble, the binding of SARS-CoV-2’s spike protein to bacterial lipopolysaccharide supercharges inflammation in COVID-19 patients.

The detailed structure of a testosterone-regulating enzyme is helping researchers to design better drugs for diseases such as prostate cancer.

Researchers have identified a pain pathway that suppresses hunger, opening the door to understanding how pain quells other competing behaviors.

Asian oil blends rich in healthy fats and phytonutrients are as good as—or even better than—olive oil for the heart.

When combined with low doses of antibiotics, this biodegradable polymer can reduce or even reverse antimicrobial resistance.

Liver tumors gain immune tolerance by activating cellular mechanisms involved in fetal development.

For the first time, researchers have generated lab-grown livers that have functioning bile canaliculi, an important step towards modeling complex liver diseases.

The mosquito-borne virus dodges immune clearance by cloaking itself in disarmed antibodies.

A new sequencing technique called PORE-cupine combines artificial intelligence to reveal ribonucleic acid structures in cells.

A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.

The discovery of how aging impacts memory T cells may unlock novel therapeutic targets to boost immune protection in older adults.